The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tiziana Life Sciences has announced that its TZLS-501 treatment could be a potential treatment for patients infected with coronavirus (COVID-19) who ...
read more
INTERPHEX announced the postponed events will take place on July 15-17, 2020 at the Javits Center in New York City.
read more
Denovo Biopharma has successfully discovered a novel genetic biomarker associated with DB104 response to treat depression using its proprietary ...
read more
I-Mab Biopharma is initiating the development of TJM2 (TJ003234) to treat cytokine storm in severe and critically ill patients caused by the ...
read more
FDA, Thermo Fisher Scientific
Thermo Fisher Scientific announced the FDA issued an EUA for its diagnostic test that can be used immediately to detect nucleic acid from SARS-CoV-2, ...
read more
CureVac AG has confirmed internal efforts are focused on the development of a coronavirus vaccine.
read more
Agenus announced the FDA has granted Agenus Fast Track designation for investigation of balstilimab in combination with zalifrelimab for relapsed or ...
read more
Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding the co-development and distribution of a potential mRNA-based ...
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Wednesday, March 18, 2020
Provention Bio announced positive top-line results from the Phase 1b portion of the PREVAIL study evaluating PRV-3279 in healthy volunteers.
read more
Wednesday, March 18, 2020
Diatherix Eurofins has developed a test for the SARS-CoV-2 virus, the cause of the COVID-19 respiratory infection, as part of its proprietary ...
read more
Biohaven announced verdiperstat received Fast Track designation from the FDA for the treatment of multiple system atrophy.
read more
At the direction of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, the Medical CBRN Defense ...
read more
Celsion announced the EMA COMP has recommended that GEN-1 be designated as an orphan medicinal product for the treatment of ovarian cancer.
read more
Samsung Bioepis announced the FDA has approved a 420 mg multi-dose vial of ONTRUZANT, a biosimilar referencing HERCEPTIN.
read more